IRAB Short Volume
Iris Acquisition Corp II (IRAB) operates in the Financial Services sector, specifically the Financial - Conglomerates industry, with a market capitalization near $172.0M, listed on NYSE, employing roughly 3 people, carrying a beta of 0.08 to the broader market. Iris Acquisition Corp II focuses on entering into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses. Led by Sumit Mehta, public since 2026-02-24.
Short volume measures the number of shares sold short on a given day as reported by FINRA. Tracking short volume relative to total volume helps identify unusual bearish sentiment or short-squeeze potential.
- Latest Date
- 2026-07-16
- Short Volume
- 3
- Total Volume
- 106
- Short %
- 2.83%
- 30-Day Avg Short %
- 43.99%
Showing 30 days of FINRA short volume data for Iris Acquisition Corp II.
Learn how short volume is reported and how to read the data →
Frequently asked IRAB short volume questions
- What is the daily IRAB short volume?
- As of Jul 16, 2026, Iris Acquisition Corp II (IRAB) short volume is 3 shares against 106 total reported volume, or 2.83% short-side. Short volume measures shares sold short during the day; it is flow, not inventory.
- How is IRAB short volume reported?
- FINRA publishes the Daily Short Sale Volume File for trades reported to FINRA TRFs and the FINRA/Nasdaq ADF on a T+1 basis. The headline figure is the count of shares that printed at the short-sale or short-exempt tick across all reporting venues for the symbol; each exchange separately publishes its own daily short-sale data file.
- What does IRAB short volume tell options traders?
- Daily short-sale flow is one input that helps disambiguate dealer-hedging activity from directional bear flow when the chain shows fresh customer call inventory. It is not a clean MM-only proxy: the headline number mixes directional shorting, options-MM delta-hedging, ETF-creation arbitrage, and convertible-arb hedging. Cross-check against gamma-exposure and OI changes for a cleaner read.